The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis
BACKGROUNDResearch evaluating the efficacy of multimodal therapy for the treatment of keloids has reported combination regimens are most effective. OBJECTIVETo compare recurrence rates for keloids treated with surgery plus one adjuvant intervention (dual therapy) versus surgery plus 2 or more adjuva...
Gespeichert in:
Veröffentlicht in: | Dermatologic surgery 2020-08, Vol.46 (8), p.1054-1059 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1059 |
---|---|
container_issue | 8 |
container_start_page | 1054 |
container_title | Dermatologic surgery |
container_volume | 46 |
creator | Ellis, Morgan M. Jones, Lamont R. Siddiqui, Farzan Sunkara, Pranit R. Ozog, David M. |
description | BACKGROUNDResearch evaluating the efficacy of multimodal therapy for the treatment of keloids has reported combination regimens are most effective.
OBJECTIVETo compare recurrence rates for keloids treated with surgery plus one adjuvant intervention (dual therapy) versus surgery plus 2 or more adjuvant interventions (triple therapy).
MATERIALS AND METHODSSystematic literature review and meta-analysis of combination treatment for keloids.
RESULTSAfter full-text review, we included 60 articles representing 5,547 keloids5,243 received dual therapy, 259 received triple therapy, and 45 received quadruple therapy (the latter 2 groups were combined for analysis). The difference in recurrence rates between dual (19%) and triple therapy (11.2%) was not significant (p = .343). However, the difference in recurrence rates between dual therapy using surgery and radiation (18.7%) and triple therapy using surgery, radiation, and a third intervention (7.7%) was significant (p = .002). The differences for surgery and intralesional triamcinolone (TAC) showed trends toward significance, because keloids treated with dual therapy (21.7%) had a higher recurrence rate than those treated with triple therapy comprised of surgery, TAC, and another intervention (13.7%; p = .099).
CONCLUSIONTriple therapy using surgery plus radiation and/or TAC as one of the adjuvant treatment modalities may achieve the lowest recurrence rates for keloids. |
doi_str_mv | 10.1097/DSS.0000000000002362 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_DSS_0000000000002362</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32224709</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4012-5823c1c5a069e22289d0d1e00642a03443c11ec9b7da927b24b877e75ecb3f2f3</originalsourceid><addsrcrecordid>eNqFkN9u0zAUh60JxP7xBhPyC2Q7PnHqhLtqdGzaJtBariPHOaEeTlLZzkqfgNeepwJCXIBv7CN_30_2j7EzAecCKnXxYbk8hz8W5jM8YEeiQJlJhcWrdAY1y6AQeMiOQ3gEEFjl8IYd5ogoFVRH7MdqTXzRddZos-Njx5eT_5oGxxffjQ12HPhnNwU-bx-nJz1Efj-5aPuxTURSvd5YCtwOPKaclScde0pUCrolN9o2vOdzvtyFSL2O1vAHerK05Xpo-T1Fnc0H7XbBhlP2utMu0Nuf-wn7crVYXV5nd58-3lzO7zIj0-uzosTcCFNomFWUPlFWLbSCAGYSNeRSpltBpmpUqytUDcqmVIpUQabJO-zyEyb3ucaPIXjq6o23vfa7WkD90mudeq3_7jVp7_baZmp6an9Lv4pMQLkHtqOL5MM3N23J12vSLq7_ly3_oSZKosIyQ0CAMo3Zi1nlzwQqlIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Ellis, Morgan M. ; Jones, Lamont R. ; Siddiqui, Farzan ; Sunkara, Pranit R. ; Ozog, David M.</creator><creatorcontrib>Ellis, Morgan M. ; Jones, Lamont R. ; Siddiqui, Farzan ; Sunkara, Pranit R. ; Ozog, David M.</creatorcontrib><description>BACKGROUNDResearch evaluating the efficacy of multimodal therapy for the treatment of keloids has reported combination regimens are most effective.
OBJECTIVETo compare recurrence rates for keloids treated with surgery plus one adjuvant intervention (dual therapy) versus surgery plus 2 or more adjuvant interventions (triple therapy).
MATERIALS AND METHODSSystematic literature review and meta-analysis of combination treatment for keloids.
RESULTSAfter full-text review, we included 60 articles representing 5,547 keloids5,243 received dual therapy, 259 received triple therapy, and 45 received quadruple therapy (the latter 2 groups were combined for analysis). The difference in recurrence rates between dual (19%) and triple therapy (11.2%) was not significant (p = .343). However, the difference in recurrence rates between dual therapy using surgery and radiation (18.7%) and triple therapy using surgery, radiation, and a third intervention (7.7%) was significant (p = .002). The differences for surgery and intralesional triamcinolone (TAC) showed trends toward significance, because keloids treated with dual therapy (21.7%) had a higher recurrence rate than those treated with triple therapy comprised of surgery, TAC, and another intervention (13.7%; p = .099).
CONCLUSIONTriple therapy using surgery plus radiation and/or TAC as one of the adjuvant treatment modalities may achieve the lowest recurrence rates for keloids.</description><identifier>ISSN: 1076-0512</identifier><identifier>EISSN: 1524-4725</identifier><identifier>DOI: 10.1097/DSS.0000000000002362</identifier><identifier>PMID: 32224709</identifier><language>eng</language><publisher>United States: Lippincott Williams & Wilkins</publisher><subject>Anti-Inflammatory Agents - therapeutic use ; Chemotherapy, Adjuvant ; Combined Modality Therapy - methods ; Dermatologic Surgical Procedures ; Humans ; Injections, Intralesional ; Keloid - therapy ; Radiotherapy, Adjuvant ; Recurrence ; Triamcinolone - therapeutic use</subject><ispartof>Dermatologic surgery, 2020-08, Vol.46 (8), p.1054-1059</ispartof><rights>Lippincott Williams & Wilkins</rights><rights>2020 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4012-5823c1c5a069e22289d0d1e00642a03443c11ec9b7da927b24b877e75ecb3f2f3</citedby><cites>FETCH-LOGICAL-c4012-5823c1c5a069e22289d0d1e00642a03443c11ec9b7da927b24b877e75ecb3f2f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32224709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ellis, Morgan M.</creatorcontrib><creatorcontrib>Jones, Lamont R.</creatorcontrib><creatorcontrib>Siddiqui, Farzan</creatorcontrib><creatorcontrib>Sunkara, Pranit R.</creatorcontrib><creatorcontrib>Ozog, David M.</creatorcontrib><title>The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis</title><title>Dermatologic surgery</title><addtitle>Dermatol Surg</addtitle><description>BACKGROUNDResearch evaluating the efficacy of multimodal therapy for the treatment of keloids has reported combination regimens are most effective.
OBJECTIVETo compare recurrence rates for keloids treated with surgery plus one adjuvant intervention (dual therapy) versus surgery plus 2 or more adjuvant interventions (triple therapy).
MATERIALS AND METHODSSystematic literature review and meta-analysis of combination treatment for keloids.
RESULTSAfter full-text review, we included 60 articles representing 5,547 keloids5,243 received dual therapy, 259 received triple therapy, and 45 received quadruple therapy (the latter 2 groups were combined for analysis). The difference in recurrence rates between dual (19%) and triple therapy (11.2%) was not significant (p = .343). However, the difference in recurrence rates between dual therapy using surgery and radiation (18.7%) and triple therapy using surgery, radiation, and a third intervention (7.7%) was significant (p = .002). The differences for surgery and intralesional triamcinolone (TAC) showed trends toward significance, because keloids treated with dual therapy (21.7%) had a higher recurrence rate than those treated with triple therapy comprised of surgery, TAC, and another intervention (13.7%; p = .099).
CONCLUSIONTriple therapy using surgery plus radiation and/or TAC as one of the adjuvant treatment modalities may achieve the lowest recurrence rates for keloids.</description><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Chemotherapy, Adjuvant</subject><subject>Combined Modality Therapy - methods</subject><subject>Dermatologic Surgical Procedures</subject><subject>Humans</subject><subject>Injections, Intralesional</subject><subject>Keloid - therapy</subject><subject>Radiotherapy, Adjuvant</subject><subject>Recurrence</subject><subject>Triamcinolone - therapeutic use</subject><issn>1076-0512</issn><issn>1524-4725</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkN9u0zAUh60JxP7xBhPyC2Q7PnHqhLtqdGzaJtBariPHOaEeTlLZzkqfgNeepwJCXIBv7CN_30_2j7EzAecCKnXxYbk8hz8W5jM8YEeiQJlJhcWrdAY1y6AQeMiOQ3gEEFjl8IYd5ogoFVRH7MdqTXzRddZos-Njx5eT_5oGxxffjQ12HPhnNwU-bx-nJz1Efj-5aPuxTURSvd5YCtwOPKaclScde0pUCrolN9o2vOdzvtyFSL2O1vAHerK05Xpo-T1Fnc0H7XbBhlP2utMu0Nuf-wn7crVYXV5nd58-3lzO7zIj0-uzosTcCFNomFWUPlFWLbSCAGYSNeRSpltBpmpUqytUDcqmVIpUQabJO-zyEyb3ucaPIXjq6o23vfa7WkD90mudeq3_7jVp7_baZmp6an9Lv4pMQLkHtqOL5MM3N23J12vSLq7_ly3_oSZKosIyQ0CAMo3Zi1nlzwQqlIQ</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Ellis, Morgan M.</creator><creator>Jones, Lamont R.</creator><creator>Siddiqui, Farzan</creator><creator>Sunkara, Pranit R.</creator><creator>Ozog, David M.</creator><general>Lippincott Williams & Wilkins</general><general>by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20200801</creationdate><title>The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis</title><author>Ellis, Morgan M. ; Jones, Lamont R. ; Siddiqui, Farzan ; Sunkara, Pranit R. ; Ozog, David M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4012-5823c1c5a069e22289d0d1e00642a03443c11ec9b7da927b24b877e75ecb3f2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Chemotherapy, Adjuvant</topic><topic>Combined Modality Therapy - methods</topic><topic>Dermatologic Surgical Procedures</topic><topic>Humans</topic><topic>Injections, Intralesional</topic><topic>Keloid - therapy</topic><topic>Radiotherapy, Adjuvant</topic><topic>Recurrence</topic><topic>Triamcinolone - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ellis, Morgan M.</creatorcontrib><creatorcontrib>Jones, Lamont R.</creatorcontrib><creatorcontrib>Siddiqui, Farzan</creatorcontrib><creatorcontrib>Sunkara, Pranit R.</creatorcontrib><creatorcontrib>Ozog, David M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Dermatologic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ellis, Morgan M.</au><au>Jones, Lamont R.</au><au>Siddiqui, Farzan</au><au>Sunkara, Pranit R.</au><au>Ozog, David M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis</atitle><jtitle>Dermatologic surgery</jtitle><addtitle>Dermatol Surg</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>46</volume><issue>8</issue><spage>1054</spage><epage>1059</epage><pages>1054-1059</pages><issn>1076-0512</issn><eissn>1524-4725</eissn><abstract>BACKGROUNDResearch evaluating the efficacy of multimodal therapy for the treatment of keloids has reported combination regimens are most effective.
OBJECTIVETo compare recurrence rates for keloids treated with surgery plus one adjuvant intervention (dual therapy) versus surgery plus 2 or more adjuvant interventions (triple therapy).
MATERIALS AND METHODSSystematic literature review and meta-analysis of combination treatment for keloids.
RESULTSAfter full-text review, we included 60 articles representing 5,547 keloids5,243 received dual therapy, 259 received triple therapy, and 45 received quadruple therapy (the latter 2 groups were combined for analysis). The difference in recurrence rates between dual (19%) and triple therapy (11.2%) was not significant (p = .343). However, the difference in recurrence rates between dual therapy using surgery and radiation (18.7%) and triple therapy using surgery, radiation, and a third intervention (7.7%) was significant (p = .002). The differences for surgery and intralesional triamcinolone (TAC) showed trends toward significance, because keloids treated with dual therapy (21.7%) had a higher recurrence rate than those treated with triple therapy comprised of surgery, TAC, and another intervention (13.7%; p = .099).
CONCLUSIONTriple therapy using surgery plus radiation and/or TAC as one of the adjuvant treatment modalities may achieve the lowest recurrence rates for keloids.</abstract><cop>United States</cop><pub>Lippincott Williams & Wilkins</pub><pmid>32224709</pmid><doi>10.1097/DSS.0000000000002362</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1076-0512 |
ispartof | Dermatologic surgery, 2020-08, Vol.46 (8), p.1054-1059 |
issn | 1076-0512 1524-4725 |
language | eng |
recordid | cdi_crossref_primary_10_1097_DSS_0000000000002362 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Anti-Inflammatory Agents - therapeutic use Chemotherapy, Adjuvant Combined Modality Therapy - methods Dermatologic Surgical Procedures Humans Injections, Intralesional Keloid - therapy Radiotherapy, Adjuvant Recurrence Triamcinolone - therapeutic use |
title | The Efficacy of Surgical Excision Plus Adjuvant Multimodal Therapies in the Treatment of Keloids: A Systematic Review and Meta-Analysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T12%3A55%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Efficacy%20of%20Surgical%20Excision%20Plus%20Adjuvant%20Multimodal%20Therapies%20in%20the%20Treatment%20of%20Keloids:%20A%20Systematic%20Review%20and%20Meta-Analysis&rft.jtitle=Dermatologic%20surgery&rft.au=Ellis,%20Morgan%20M.&rft.date=2020-08-01&rft.volume=46&rft.issue=8&rft.spage=1054&rft.epage=1059&rft.pages=1054-1059&rft.issn=1076-0512&rft.eissn=1524-4725&rft_id=info:doi/10.1097/DSS.0000000000002362&rft_dat=%3Cpubmed_cross%3E32224709%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32224709&rfr_iscdi=true |